This clinical trial is focused on studying the use of remifentanil for helping with the process of endotracheal intubation in newborns. Endotracheal intubation is a medical procedure where a tube is placed into a baby’s windpipe to help them breathe. The study involves newborns who are stable in terms of their heart and blood pressure and need this procedure done in a planned manner. The main goal is to find the right dose of remifentanil that provides effective sedation, which means making the baby calm and comfortable during the procedure, with minimal side effects.
The trial will use remifentanil, a medication given through an injection, to see how well it works in providing the right conditions for intubation. Another solution, sodium chloride, will be used to help with the administration of the medication. The study will observe how the babies respond to the medication, focusing on how well they are sedated and how smoothly the intubation process goes. The researchers will also monitor for any side effects, such as changes in heart rate or breathing, to ensure the safety of the newborns.
The study aims to determine the best dose of remifentanil for newborns, both those born at full term and those born prematurely, to ensure the procedure is as safe and effective as possible. The researchers will assess the level of sedation by gently stimulating the baby’s foot and observing their response. The trial will also look at how quickly the babies recover their normal breathing after the procedure and check for any other health concerns that might arise. This research is important for improving the care and comfort of newborns who need this critical medical procedure.
Belgium 